Weekly updateCompaniesRecruiting servicePost a job
Affini-T Therapeutics

Affini-T Therapeutics

    Company info:

  • 1-50
  • 2021
  • Watertown, MA
  • not disclosed



Claim company profile

About company:

Affini-T Therapeutics is using the power of T cells to develop therapies for solid tumor cancers. T cells exhibit a cytotoxic response against tumor cells; however, T cells are repressed by the tumor cells in many cancers. Affini-T is using synthetic biology and gene editing to engineer TCR T cell therapies to target oncogenic driver mutations that cause tumors by increasing their activity. Both CD8+ and CD4+ are engineered by Affini-T to further enhance the cytotoxic response and sustained killing of tumor cells as well as to persist longer in the tumor microenvironment. With their discovery platform, Affini-T is building many oncogenic driver programs including KRAS G12V and mutant p53 that are in early development.


Claim company profile to post jobs directly on this page and this website.

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com